stoxline Quote Chart Rank Option Currency Glossary
RadNet, Inc. (RDNT)
48.5  -0.73 (-1.48%)    04-12 16:00
Open: 49.7
High: 49.7
Volume: 388,690
Pre. Close: 49.23
Low: 48.215
Market Cap: 3,542(M)
Technical analysis
2024-04-12 4:51:49 PM
Short term     
Mid term     
Targets 6-month :  58.33 1-year :  68.13
Resists First :  49.94 Second :  58.33
Pivot price 48.38
Supports First :  45.31 Second :  42.45
MAs MA(5) :  48.82 MA(20) :  47.74
MA(100) :  39.52 MA(250) :  33.83
MACD MACD :  1.4 Signal :  1.6
%K %D K(14,3) :  71.6 D(3) :  76.4
RSI RSI(14): 60.6
52-week High :  49.94 Low :  25.11
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ RDNT ] has closed below upper band by 44.7%. Bollinger Bands are 62.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 49.82 - 50.06 50.06 - 50.26
Low: 47.54 - 47.87 47.87 - 48.14
Close: 48.04 - 48.54 48.54 - 48.94
Company Description

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

Headline News

Sat, 13 Apr 2024
RadNet (NASDAQ:RDNT) Cut to “Sell” at - Defense World

Wed, 10 Apr 2024
Does RadNet (RDNT) Have a Long Runway for Growth? - Yahoo Finance

Wed, 10 Apr 2024
RadNet to Make its Second Acquisition in Houston, Texas - Yahoo Finance

Tue, 09 Apr 2024
Sowell Financial Services LLC Trims Stock Holdings in RadNet, Inc. (NASDAQ:RDNT) - Defense World

Mon, 08 Apr 2024
Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value? - Simply Wall St

Mon, 08 Apr 2024
RadNet, Inc. (NASDAQ:RDNT) Stock Holdings Trimmed by State of Alaska Department of Revenue - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Diagnostics & Research
Shares Out 74 (M)
Shares Float 60 (M)
Held by Insiders 11.4 (%)
Held by Institutions 75 (%)
Shares Short 2,770 (K)
Shares Short P.Month 2,590 (K)
Stock Financials
EPS 0.05
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 9.27
Profit Margin 0.1 %
Operating Margin 7.4 %
Return on Assets (ttm) 2.3 %
Return on Equity (ttm) 4.6 %
Qtrly Rev. Growth 9.5 %
Gross Profit (p.s.) 0
Sales Per Share 21.97
EBITDA (p.s.) 3.05
Qtrly Earnings Growth 0 %
Operating Cash Flow 221 (M)
Levered Free Cash Flow 27 (M)
Stock Valuations
PE Ratio 970
PEG Ratio 5.8
Price to Book value 5.22
Price to Sales 2.2
Price to Cash Flow 16.18
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android